A phase II trial of temozolomide for patients with recurrent or progressive brain metastases (Q33339923)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A phase II trial of temozolomide for patients with recurrent or progressive brain metastases	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

0 references

0 references

author name string

L E Abrey

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J D Olson

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J J Raizer

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Mack

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Rodavitch

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D Y Boutros

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M G Malkin

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

259-265

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The role of radiation therapy in the treatment of brain metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of hyperfractionated re-irradiation in metastatic brain disease: a single institutional trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent brain metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reoperation for recurrent metastatic brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of cerebral metastases from solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of temozolomide against human tumor colony-forming units

1 reference

https://pubmed.ncbi.nlm.nih.gov/11718258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1012226718323

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33339923&oldid=2195260452"